IP Library Granted Patent US 11,712,292
Granted Patent B2
US 11,712,292 · App. 17/691,032 · Granted Aug 1, 2023

Fundus bumper mechanical reference for easier mechanism deployment

Inventors: Thomas C. Kochem (Watertown, MA); Daniel A. Beaudet (Lexington, MA)
Assignee: Hologic, Inc.
A61B18/1485A61B17/0218A61B17/42A61B17/4241A61F6/18A61B2017/4216A61B2018/00065A61B2018/00071A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/1465A61B2090/065A61B2090/08021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,712,292
App. No.
17/691,032
Granted
Aug 1, 2023
Kind
B2
Abstract

Intrauterine devices and methods for facilitating deployment thereof using a bumper are disclosed. In one embodiment, an intrauterine device comprises a structure including a first central support member and a deployment mechanism coupled to the first central support member. The intrauterine device further comprises a bumper positioned at a distal end of a second central support member and at a more distal position relative to a distal end of the structure so as to prevent the distal end of the structure from contacting the fundus of the uterus of a patient during deployment of the deployment mechanism. In another embodiment, the intrauterine device comprises a bumper coupled to the deployment mechanism and configured to move from a more distal to a more proximal position relative to a distal end of the structure.

Claims (13)

1. A method of positioning an intrauterine ablation device in a uterus, comprising:

transcervically inserting a distal end portion of the intrauterine ablation device into the uterus, the distal end portion of the intrauterine ablation device comprising a first flexure distal free end, a second flexure distal free end, and a distal bumper disposed laterally therebetween, wherein a distal facing end of the distal bumper is distal to the first and second flexure distal free ends;

advancing the distal end portion of the intrauterine ablation device within the uterus until the distal bumper contacts a fundal wall of the uterus; and

while the distal bumper is contacting the fundal wall, manipulating the distal end portion of the intrauterine ablation device so that the respective first and second flexure distal free ends move laterally away from one another in opposite directions without engaging the fundal wall.

2. The method of claim 1 , wherein manipulating the distal end portion of the intrauterine ablation device comprises expanding the distal end portion of the intrauterine ablation device from a collapsed configuration, in which the first and second flexure distal free ends are closely apposed to one another for transcervical introduction into the uterus, and an expanded configuration, in which the first and second flexure distal free ends extend laterally away from one another in opposite directions.

3. The method of claim 2 , wherein the distal bumper is configured to conform to the fundal wall when the first and second flexures are in the expanded configuration.

4. The method of claim 2 , wherein the distal bumper extends transversely between the first and second flexures when the first and second flexures are in the expanded configuration.

5. The method of claim 2 , wherein the distal bumper has a curved shape when the first and second flexures are in the expanded configuration.

6. The method of claim 1 , wherein the distal bumper comprises a flexible ribbon and/or a thin flexible membrane.

7. The method of claim 1 , wherein the distal bumper comprises one or more of an 5 electrically conductive material, a porous material, a hydrophilic material, a conductive polymer, and a material infused with an electrically conductive particulate.

8. The method of claim 1 , further comprising a flexible tissue contacting member overlaying the first and second flexures and configured for delivering ablative energy to an endometrial lining of the uterus.

9. The method of claim 8 , wherein the distal bumper is coupled to the tissue contacting member.

10. The method of claim 1 , wherein the distal bumper is configured to maintain separation between the fundal wall and the first and second flexure distal free ends as the first and second flexures move laterally away from one another.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 065286/0407 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE PRODESSE, INC.
Reel/Frame 075457/0767 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 19, 2023
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 065286/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2022
From: KOCHEM, THOMAS C.; BEAUDET, DANIEL A.
To: HOLOGIC, INC.
Reel/Frame 059215/0767 →